Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts

Biomed Res Int. 2014:2014:434067. doi: 10.1155/2014/434067. Epub 2014 Jul 13.

Abstract

This paper provides evidence that the leaves and stem of Passiflora serratodigitata L. dry crude extract (DCE), ethylacetate fraction (EAF), and residual water fraction show potential antiulcerogenic activity. Interestingly, the polymeric nanocapsule loaded with EAF had 10-fold more activity than the free EAF. Furthermore, the polymer nanoparticles provided homogeneous colloidal drug delivery systems and allowed overcoming challenges such as poor aqueous solubility as well as the physical-chemical instability of the organic extract, which presented 90% (w/w) of the flavonoid content. The entrapment efficiency of the total flavonoid was 90.6 ± 2.5% (w/v) for the DCE and 79.9 ± 2.7% (w/v) for the EAF. This study shows that nanoencapsulation improves both the physicochemical properties and the efficacy of the herbal formulations. Therefore, free and encapsulated extracts have the potential to be suitable drug design candidates for the therapeutic management of ulcer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Flavonoids / administration & dosage
  • Flavonoids / chemistry
  • Humans
  • Nanocapsules / administration & dosage*
  • Nanocapsules / chemistry
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Passiflora / chemistry
  • Plant Extracts / administration & dosage*
  • Plant Extracts / chemistry
  • Rats
  • Ulcer / drug therapy*

Substances

  • Flavonoids
  • Nanocapsules
  • Plant Extracts